Medical Equipment

Drug Eluting Balloons Catheters Market Forecast: How Big Will It Be by 2030?

February 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Drug Eluting Balloons Catheters Market?

The drug eluting balloons catheters market has experienced substantial expansion in recent years. Projections indicate that this market will expand from $1.65 billion in 2025 to $1.86 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 12.5%. This historical growth can be linked to several factors, including the rising incidence of coronary artery disease, increased uptake of percutaneous coronary interventions, improvements in balloon catheter materials, widespread clinical acceptance of paclitaxel-coated devices, and the proliferation of interventional cardiology centers.

The drug eluting balloons catheters market size is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $2.92 billion, expanding at a compound annual growth rate (CAGR) of 11.9%. Factors contributing to this growth during the forecast period include a rising demand for minimally invasive vascular treatments, greater acceptance of sirolimus-based balloons, the broadening scope of peripheral vascular disease therapies, increased funding for advanced catheter technologies, and a heightened emphasis on durable patient results. Key developments expected in the forecast period encompass the wider embrace of drug-coated balloon technologies, an uptick in their application for coronary and peripheral procedures, a growing inclination towards treatment alternatives that do not involve stents, the proliferation of sophisticated drug coating methods, and a sharpened focus on preventing restenosis.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13429&type=smp

Which Drivers Are Supporting The Rise Of The Drug Eluting Balloons Catheters Market?

The increasing incidence of peripheral and cardiovascular diseases is anticipated to drive the expansion of the drug-eluting balloon catheter market in the future. Cardiovascular diseases (CVDs) encompass various ailments affecting the heart and circulatory system, while peripheral artery disease (PAD) is characterized by constricted arteries limiting blood supply, mainly to the limbs. Drug-eluting balloon catheters serve as a treatment method for coronary artery disease (CAD), utilizing a semi-compliant angioplasty balloon infused with an anti-proliferative agent, which produces an anti-restenotic impact upon deployment within a vessel. As an illustration, the American Heart Association, a US-based non-profit organization, reported in January 2024 that the age-adjusted cardiovascular disease mortality rate increased to 233.3 deaths per 100,000 in 2024, representing a 4.0% year-on-year rise from 224.4 deaths per 100,000 in 2023. Consequently, the expanding occurrence of peripheral and cardiovascular diseases is fueling the drug-eluting balloon catheter market.

What Leading Segments Are Studied In The Drug Eluting Balloons Catheters Market?

The drug eluting balloons catheters market covered in this report is segmented –

1) By Product: Coronary Artery Disease, Peripheral Vascular Disease, Drug-Eluting Balloon Catheters

2) By Drug: Paclitaxel, Sirolimus, Other Drugs

3) By Raw Material: Nylon, Polyurethane, Other Raw Materials

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Catheterization Laboratories

Subsegments:

1) By Coronary Artery Disease: Coronary Drug-Eluting Balloon Catheters, Coronary In-Stent Restenosis Drug-Eluting Balloon Catheters, Coronary Small-Vessel Drug-Eluting Balloon Catheters

2) By Peripheral Vascular Disease: Drug-Eluting Balloon Catheters, Femoro-Popliteal Drug-Eluting Balloon Catheters, Below-the-Knee (BTK) Drug-Eluting Balloon Catheters

3) By Drug-Eluting Balloon Catheters: Drug-Eluting Angioplasty Balloon Catheters

Which Market Trends Are Opening Growth Opportunities In The Drug Eluting Balloons Catheters Market?

Major companies in the drug-eluting balloon catheter market are increasingly focused on developing advanced, newest-generation products to secure a competitive advantage. For instance, in March 2024, Boston Scientific Corporation, a US-based biomedical/biotechnology engineering firm and multinational medical device manufacturer, announced it received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB). The AGENT DCB is the first drug-coated coronary balloon available in the U.S. for treating in-stent restenosis (ISR), a condition where plaque or scar tissue blocks a stented vessel. It features a paclitaxel coating that delivers a therapeutic dose to the vessel wall, effectively reducing ISR recurrence without requiring additional stents or radiation. Clinical trials revealed a 49% decrease in heart attack risk at the target site and reported low rates of adverse events.

Which Major Firms Are Strengthening Their Position In The Drug Eluting Balloons Catheters Market?

Major companies operating in the drug eluting balloons catheters market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

Which Regions Are Poised For Strategic Growth In The Drug Eluting Balloons Catheters Market?

North America was the largest region in the drug eluting balloons catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Drug Eluting Balloons Catheters Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13429&type=smp

Browse Through More Reports Similar to the Global Drug Eluting Balloons Catheters Market 2026, By The Business Research Company

Drug Coated Balloons Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Pta Balloon Catheter Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report

Deflectable Catheters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/deflectable-catheters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795